
¿Qué afecta tus posibilidades de sobrevivir al cáncer de cuello uterino?
Revisado por pares por Dr Krishna Vakharia, MRCGPÚltima actualización por Gillian HarveyLast updated 19 Jan 2024
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
Despite the strong preventative measures in place, 3,200 cases of cervical cancer are diagnosed every year in the UK. And according to Cancer Research UK, more than 50% of those diagnosed survive for 10 years or more.
Here we look at what can affect cervical cancer survival rates.
En este artículo:
Video picks for Cáncer ginecológico
Continúa leyendo abajo
What's the survival rate of cervical cancer?
The survival rate for cervical cancer depends on many different factors, such as your age and health, but one of the most important factors is how early it is diagnosed. In its early stages, or at the first signs of cell changes that might lead to cancer, cervical cancer can be effectively treated. However, late diagnosis can make an enormous difference.
"Early diagnosis is incredibly important with cervical cancer," says molecular engineer and cancer researcher, Dr Angela Pine. Of those diagnosed with stage 1 cervical cancer, more than 90% will survive for more than a year. But with a diagnosis of stage 4, that number drops to 50%."
We explore what can affect your chances of survival from cervical cancer.
Improvements in treatment
Volver al contenidoResearch into preventing and treating all types of cancer is ongoing, with new treatments on the horizon. And, like many other forms of cancer, the survival rate for cervical cancer has improved over the past decade.
"We have seen survival rates in the UK improve and they have been doing so for quite some time," says Pine. She adds that this may have changed during the pandemic years due to reduced access for cervical screening appointments, but data has yet to be released.
There is no doubt the progress made should be celebrated. However, the screening and preventative measures available for cervical cancer could almost eliminate the disease entirely1, so there is still much to be done.
Continúa leyendo abajo
Attending your cervical screening
Volver al contenidoCervical screening is effective at identifying or ruling out the woman at risk of cervical cancer. However, only 40-50% of women and people with cervices who are invited for a screening test take up the offer.
The screening tests both for high-risk HPV (Human Papillion Virus - a virus transmitted by close bodily contact and responsible for 99.8% of cervical cancer cases) - and for pre-cancerous cells. Therefore, attending the test could mean that your cancer can be treated and eliminated before it takes a meaningful hold.
Low uptake of screening tests, however, means that in many cases, cervical cancer is being diagnosed at a later stage than it should be.
Also, a vaccine programme against HPV has been in place since 2009 for girls - and 2016 for boys - that aims to protect people from contracting the virus in the first place. While uptake of the vaccine is fairly high - around 70% - this rate could still be improved.
There are a number of reasons why women may be hesitant to attend their cervical screening (smear test).
Discomfort and embarrassment
The screening involves a sample of cells being taken from the cervix. Although pain is minimal, the procedure can be uncomfortable and feel scary. And because it is a gynaecological examination, some women may find it embarrassing.
Fear or trauma
Some women feel reluctant to attend the test because of its invasive nature. The idea of a gynaecological examination can be daunting for some, and may even be traumatic - especially to survivors of sexual abuse.
Lack of understanding
While charities and health care providers are working hard to get the message out there, not everyone fully understands the importance of cervical cancer screening, or realises the important part it plays in cancer prevention. There are also several myths that can put women off attending.
Spotting the symptoms
Volver al contenidoIf you miss your cervical screening or are overdue your screening - book in with your GP practice to get your cervical screening as soon as you can, otherwise, the only other way to spot cervical cancer is once you have symptoms. In its early stages, cervical cancer is usually symptom free. This means that if you rely on symptom spotting alone, you could be diagnosed late when the cancer has already progressed.
It's also possible that if you do have symptoms, it can take a while for them to be linked with cervical cancer. This is because they can also be a sign of other health problems that a doctor has to investigate and rule out.
Common symptoms of cervical cancer include
Bleeding after sex.
Pain or discomfort during sex.
Unusual vaginal bleeding - bleeding in between periods or periods are longer or heavier.
Changes to vaginal discharge.
Bleeding after menopause.
Pain in your lower back, pelvis and stomach that doesn't go away
All of these symptoms could be signs of something other than cervical cancer, but don't dismiss or ignore them. It's important to seek medical advice if you experience the above symptoms and, if necessary, to raise the possibility of cervical cancer with your doctor.
"It's about knowing your body and what's normal for you" explains Kate Sanger, spokesperson for cervical cancer charity Jo's Trust. "Make sure you outline the symptoms carefully to your GP. There is guidance available for clinicians, and if you present with these symptoms they need to explore further into all possible causes."
Continúa leyendo abajo
Lectura adicional
Volver al contenidoPain in your lower back, pelvis and lower stomach.
Patient picks for Cáncer ginecológico

Cáncer
Las bacterias 'amigables' en la vagina podrían proteger contra el cáncer de ovario
Tener muy pocas bacterias 'amigables' en la vagina podría aumentar el riesgo de cáncer de ovario, sugiere una nueva investigación.
por Milly Evans

Cáncer
¿Las mujeres lesbianas y bisexuales todavía necesitan hacerse pruebas de Papanicolaou?
El cáncer de cuello uterino es el cáncer más común en mujeres de 35 años y menos, con alrededor de 3,000 mujeres diagnosticadas cada año en el Reino Unido. A pesar de esto, solo el 72 por ciento de las mujeres elegibles en Inglaterra asisten a las pruebas de detección cervical (o citologías), que pueden ayudar a detectar células anormales temprano y prevenir alrededor del 75 por ciento de los cánceres de cuello uterino. Sin embargo, en la comunidad LGBT+ las cifras son aún mucho más bajas. Según Lawrie Roberts, Coordinador del Programa LGBT y Cáncer de Macmillan en la Fundación LGBT, aproximadamente la mitad (51 por ciento) de las mujeres elegibles que tienen sexo con mujeres nunca han asistido a una prueba de citología.
por Sarah Graham
Continúa leyendo abajo
Historial del artículo
La información en esta página es revisada por pares por clínicos calificados.
19 Jan 2024 | Última versión
19 Jan 2024 | Publicado originalmente

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
By subscribing you accept our Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.